The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online June 17, 2009
The Journal of Immunology, 2009, 183, 145 -154
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803277

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0803277v1
183/1/145    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Brenk, M.
Right arrow Articles by von Bubnoff, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brenk, M.
Right arrow Articles by von Bubnoff, D.

Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells1

Manuela Brenk*, Marina Scheler*, Susanne Koch*, Jürgen Neumann{dagger}, Osamu Takikawa{ddagger}, Georg Häcker§, Thomas Bieber2,* and Dagmar von Bubnoff2,3,*

* Department of Dermatology and Allergy, Friedrich-Wilhelms-University of Bonn, Bonn, Germany; {dagger} Institute of Genetics, Friedrich-Wilhelms-University of Bonn, Bonn, Germany; {ddagger} National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Aichi, Japan; and § Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, Munich, Germany

Tryptophan catabolism through IDO activity can cause nonresponsiveness and tolerance acting on T cells. Given the crucial importance of dendritic cells (DCs) in the initiation of a T cell response, surprisingly little is known about the impact of IDO activity and tryptophan deprivation on DCs themselves. In the present study, we show that human DCs differentiated under low-tryptophan conditions acquire strong tolerogenic capacity. This effect is associated with a markedly decreased Ag uptake as well as the down-regulation of costimulatory molecules (CD40, CD80). In contrast, the inhibitory receptors ILT3 and ILT4 are significantly increased. Functionally, tryptophan-deprived DCs show a reduced capacity to stimulate T cells, which can be restored by blockade of ILT3. Moreover, ILT3highILT4high DCs lead to the induction of CD4+CD25+ Foxp3+ T regulatory cells with suppressive activity from CD4+CD25 T cells. The generation of ILT3highILT4high DCs with tolerogenic properties by tryptophan deprivation is linked to a stress response pathway mediated by the GCN2 kinase. These results demonstrate that tryptophan degradation establishes a regulatory microenvironment for DCs, enabling these cells to induce T regulatory cells. The impact of IDO thus extends beyond local immune suppression to a systemic control of the immune response.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 704/TP A15) and BONFOR.

2 T.B. and D.v.B. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Dagmar von Bubnoff, Department of Dermatology and Allergy, Friedrich-Wilhelms-University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany. E-mail address: d.bubnoff{at}uni-bonn.de

4 Abbreviations used in this paper: DC, dendritic cell; 7-AAD, 7-aminoactinomycin D; CHOP, C/EBP-homologous protein; iDC, immature DC; ILT, Ig-like transcript; mDC, mature DC; MFI, median fluorescence intensity; poly(I:C), polyriboinosinic-polyribocytidylic acid; rFI, relative fluorescence index; Treg, regulatory T cell; Trp, tryptophan; TT, tetanus toxoid.

5 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.